Conditional loss of heparin-binding EGF-like growth factor results in enhanced liver fibrosis after bile duct ligation in mice
- 3 June 2013
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 437 (2), 185-191
- https://doi.org/10.1016/j.bbrc.2013.05.097
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Heparin-binding epidermal growth factor-like growth factor suppresses experimental liver fibrosis in miceLaboratory Investigation, 2012
- Heparin‐binding epidermal growth factor‐like growth factor as a novel targeting molecule for cancer therapyCancer Science, 2006
- ErbB and HB-EGF Signaling in Heart Development and FunctionCell Structure and Function, 2006
- Liver fibrosisJCI Insight, 2005
- Liver fibrosis – from bench to bedsideJournal of Hepatology, 2003
- Liver regeneration in heparin-binding EGF-like growth factor transgenic mice after partial hepatectomyGastroenterology, 2003
- Effects of Exogenous Human Heparin-Binding Epidermal Growth Factor-Like Growth Factor on DNA Synthesis of Hepatocytes in Normal Mouse LiverBiochemical and Biophysical Research Communications, 1999
- Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity.Molecular Biology of the Cell, 1995
- Heparin-Binding EGF-like Growth-Factor Is a Potent Mitogen for Rat HepatocytesBiochemical and Biophysical Research Communications, 1994
- A Heparin-Binding Growth Factor Secreted by Macrophage-Like Cells That Is Related to EGFScience, 1991